ContactCredit ReportFinancialsPeopleOwnershipLatest ActivityMutual CompaniesDocumentsRepayment History

Sitryx Therapeutics Limited

Sitryx Therapeutics Limited is an active company incorporated on 8 September 2016 with the registered office located in Oxford, Oxfordshire. Sitryx Therapeutics Limited was registered 9 years ago.
Status
Active
Active since incorporation
Company No
10366466
Private limited company
Age
9 years
Incorporated 8 September 2016
Size
Unreported
Confirmation
Due Soon
Dated 7 September 2024 (1 year ago)
Next confirmation dated 7 September 2025
Due by 21 September 2025 (13 days remaining)
Last change occurred 11 months ago
Accounts
Submitted
For period 1 Jan31 Dec 2024 (1 year)
Accounts type is Group
Next accounts for period 31 December 2025
Due by 30 September 2026 (1 year remaining)
Contact
Address
101 Bellhouse Building Magdalen Centre
The Oxford Science Park
Oxford
OX4 4GA
Same address for the past 4 years
Telephone
01865 648401
Email
Unreported
Website
People
Officers
11
Shareholders
34
Controllers (PSC)
1
Director • American • Lives in United States • Born in May 1960
Director • Vice President Search, Evaluations & Tra • American,canadian • Lives in United States • Born in Jul 1987
Director • SVP R&D Pipeline And Chief Immunology OF • Dutch • Lives in England • Born in Dec 1959
Director • Corporate Business Development Professio • American • Lives in United States • Born in May 1972
Director • VC Partner • Dutch • Lives in Netherlands • Born in Nov 1988
Shareholders, PSCs & Group Structure
See who truly controls a company with full PSC, Shareholder, and Group Structure exploration
Mutual Companies
Mestag Therapeutics Ltd
Dame Catherine Elizabeth Bingham and Dr Andrew Neil Charles Weir are mutual people.
Active
SV Health Investors UK Limited
Dame Catherine Elizabeth Bingham is a mutual person.
Active
Pulmocide Limited
Dame Catherine Elizabeth Bingham is a mutual person.
Active
Autifony Therapeutics Limited
Dame Catherine Elizabeth Bingham is a mutual person.
Active
Enara Bio Limited
Dame Catherine Elizabeth Bingham is a mutual person.
Active
Quell Therapeutics Limited
Dame Catherine Elizabeth Bingham is a mutual person.
Active
Alchemab Therapeutics Ltd
Dame Catherine Elizabeth Bingham is a mutual person.
Active
Eyebiotech Limited
Dame Catherine Elizabeth Bingham is a mutual person.
Active
Financials
Net Assets, Total Assets & Total Liabilities (2017–2024)
Period Ended
31 Dec 2024
For period 31 Dec31 Dec 2024
Traded for 12 months
Cash in Bank
£29.51M
Decreased by £4.8M (-14%)
Turnover
£23.31M
Increased by £23.31M (%)
Employees
46
Increased by 1 (+2%)
Total Assets
£34.53M
Decreased by £5.67M (-14%)
Total Liabilities
-£6.39M
Decreased by £10.4M (-62%)
Net Assets
£28.14M
Increased by £4.73M (+20%)
Debt Ratio (%)
19%
Decreased by 23.27% (-56%)
Latest Activity
Group Accounts Submitted
3 Months Ago on 5 Jun 2025
Iain Charles Kilty Appointed
11 Months Ago on 1 Oct 2024
Confirmation Submitted
11 Months Ago on 19 Sep 2024
Small Accounts Submitted
1 Year 2 Months Ago on 11 Jun 2024
Garrett Rhyasen Appointed
1 Year 4 Months Ago on 15 Apr 2024
Rabinder Kumar Prinjha Resigned
1 Year 4 Months Ago on 15 Apr 2024
Sanne Dejongh Appointed
1 Year 11 Months Ago on 18 Sep 2023
Confirmation Submitted
1 Year 12 Months Ago on 11 Sep 2023
Small Accounts Submitted
2 Years 1 Month Ago on 27 Jul 2023
Dr Rabinder Kumar Prinjha Appointed
2 Years 4 Months Ago on 11 May 2023
Get Credit Report
Discover Sitryx Therapeutics Limited's Credit Score, how much credit you can offer them, and how likely they are to repay you
Documents
Statement of capital following an allotment of shares on 30 May 2025
Submitted on 12 Jun 2025
Group of companies' accounts made up to 31 December 2024
Submitted on 5 Jun 2025
Statement of capital following an allotment of shares on 1 May 2025
Submitted on 4 Jun 2025
Statement of capital following an allotment of shares on 7 February 2025
Submitted on 11 Apr 2025
Statement of capital following an allotment of shares on 1 October 2024
Submitted on 31 Jan 2025
Appointment of Iain Charles Kilty as a director on 1 October 2024
Submitted on 18 Oct 2024
Resolutions
Submitted on 12 Oct 2024
Confirmation statement made on 7 September 2024 with updates
Submitted on 19 Sep 2024
Accounts for a small company made up to 31 December 2023
Submitted on 11 Jun 2024
Appointment of Garrett Rhyasen as a director on 15 April 2024
Submitted on 13 May 2024
Repayment History
Understand how businesses repay their debts and see how they're performing year‐on‐year